What is The Cooper Companies, Inc.'s (COO) StockRank?

MoatMap's StockRank for The Cooper Companies, Inc. (COO) is 54/100, with a Hold signal. This is a composite score combining Quality (52), Value (37), and Momentum (58) factor ranks across MoatMap's 20,000+ stock universe.

Does The Cooper Companies, Inc. have an economic moat?

The Cooper Companies, Inc. (COO) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is The Cooper Companies, Inc. a buy, hold, or sell?

MoatMap's current signal for The Cooper Companies, Inc. (COO) is Hold, based on a StockRank of 54/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is The Cooper Companies, Inc. in?

The Cooper Companies, Inc. (COO) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

COO

HOLD

The Cooper Companies, Inc. · Healthcare · United States · $13.7B · Avg Vol: $189M/d

StockRank

Get insider-trade alerts

P/E (TTM)

61.2x

ROE

2.9%

D/E

0.3x

Dividend %

—

COMPANY DESCRIPTION

The Cooper Companies, Inc. is a global medical device company operating through two distinct segments: CooperVision, a leading manufacturer of contact lenses, and CooperSurgical, a provider of women's healthcare solutions. CooperVision holds a dominant position in specialty contact lenses, while CooperSurgical offers innovative products supporting fertility, diagnostics, and surgical procedures. The company's focus on high-growth, niche medical device markets, backed by strong R&D, provides a resilient business model in the healthcare sector.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR	TTM	2026E	2027E	Fwd CAGR
Revenue	3.3B	3.6B	3.9B	4.1B	7.3%	4.2B	4.3B	4.5B	5.1%
EPS	1.96	1.49	1.97	1.91	-0.7%	1.17	2.15	2.32	10.2%
Shares	197.2M	198.1M	199.6M	195.9M	-0.7%	195.0M	—	—	—
Debt	2.8B	2.6B	2.6B	2.5B	-3.2%	2.7B	—	—	—
Equity	7.2B	7.6B	8.1B	8.2B	4.7%	—	—	—	—
Op CF	692.4M	607.5M	709.3M	796.1M	4.8%	953.0M	—	—	—
Inv CF	-1.8B	-449.0M	-764.6M	-372.9M	—	—	—	—	—
Fin CF	1.2B	-173.9M	39.2M	-425.9M	—	—	—	—	—

Loading 1Y...

PRICE (1Y)+4.1%

SMA 50SMA 200

$70.31

RSI (14)

42.7

52W High

$89.83

From 52W High

0.8%

SCORE BREAKDOWN

Quality

ROIC

5.9%60.8

ROE

2.9%51.7

GP/Assets

22.4%52.6

Op. Margin

-2.9%33.6

FCF/Assets

3.4%62.2

Piotroski

668.2

Int. Cover

6.7x55.5

D/E Ratio

0.33x39.6

Current Ratio

1.27x18.7

Value

P/E (TTM)

61.2x16.4

EV/EBITDA

18.7x33.3

P/FCF

32.3x39.5

P/B

1.7x66.8

P/S

3.3x53.7

Div Yield

—N/A

Momentum

52W High %

78%68.0

RS 6M

-23%43.9

SMA 50/200

0.92x44.9

EPS Rev 4W

+0.1%78.7

EPS Rev 12W

-0.3%50.6

EPS Improve

+328%93.5

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$13.7B

P/E (Forward)

14.3x

Gross Margin

65.6%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of COO are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
COO	The Cooper Companies, Inc.(you)	$13.7B	54	HOLD
BAX	Baxter International Inc.	$11.6B	69	BUY
AVTR	Avantor, Inc.	$7.8B	62	HOLD
SOLV	Solventum Corporation	$13.5B	78	BUY
RGEN	Repligen Corporation	$7.4B	40	HOLD
ATR	AptarGroup, Inc.	$8.4B	74	BUY
TFX	Teleflex Incorporated	$5.8B	70	BUY
WST	West Pharmaceutical Services, Inc.	$23.1B	77	BUY
MMED	MiniMed Group, Inc.	$4.7B	37	HOLD
RMD	ResMed Inc.	$28.3B	78	BUY

Peer medians: ROE -25.6% · P/E 27.6x · Gross margin 50.5%

The Cooper Companies, Inc. (COO) — Stock Score Summary

The Cooper Companies, Inc. (COO) has a MoatMap StockRank of 54/100 based on Quality (52/100), Value (37/100), and Momentum (58/100) factor scores. The current signal is HOLD.

Key Financial Metrics

Price	$70.31
Market Cap	$13.7B
P/E (TTM)	61.19
P/E (Forward)	14.31
Price/Book	1.69
Return on Equity	2.9%
Return on Invested Capital	5.9%
Debt/Equity	0.33x
Gross Margin	65.6%
Operating Margin	-2.9%
Revenue Growth	7.9%
Free Cash Flow	$424M

The Cooper Companies, Inc. operates in the Medical Instruments & Supplies industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is The Cooper Companies, Inc.’s (COO) StockRank?: MoatMap’s StockRank for The Cooper Companies, Inc. (COO) is 54/100, with a Hold signal. It is a composite of Quality (52), Value (37), and Momentum (58) factor ranks across MoatMap’s 20,000+ stock universe.
Does The Cooper Companies, Inc. have an economic moat?: The Cooper Companies, Inc. (COO) has a Quality factor score of 52/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is The Cooper Companies, Inc. a buy, hold, or sell?: MoatMap’s current signal for The Cooper Companies, Inc. (COO) is Hold, based on a StockRank of 54/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is The Cooper Companies, Inc. in?: The Cooper Companies, Inc. (COO) operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry (United States).